Company intelligence / Profile preview

Jaguar

Lake Forest, Illinois, USA

Ownership: Private
Development stage: Other

Overview

Jaguar Gene Therapy has advanced multiple gene therapy programs addressing severe genetic diseases with high unmet need. The company is leveraging an AAV platform and has strengthened its leadership and manufacturing process, but has not yet reported pivotal clinical trial results as most assets are preclinical or just entering clinical development

Therapeutic areas: NeurologyEndocrinologyMetabolic Disorders
Modalities: Gene therapyAdeno-associated virus (AAV)-based therapy
Industry: Biotech

Partnerships

Deerfield ManagementArch Venture PartnersNolan Capitalresearch institutionsmanufacturing technology partners

Beyond the preview

Go deeper on Jaguar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jaguar.

Explore the full profile